Alto Neuroscience Inc. (NYSE: ANRO) kicked off on Monday, up 5.65% from the previous trading day, before settling in for the closing price of $10.45. Over the past 52 weeks, ANRO has traded in a range of $7.91-$24.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -50.00%. While this was happening, its average annual earnings per share was recorded 73.16%. With a float of $22.18 million, this company’s outstanding shares have now reached $26.88 million.
The extent of productivity of a business whose workforce counts for 63 workers is very important to gauge. In terms of profitability, gross margin is 22.31%, operating margin of -14572.58%, and the pretax margin is -13388.44%.
Alto Neuroscience Inc. (ANRO) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Alto Neuroscience Inc. is 17.74%, while institutional ownership is 68.19%. The most recent insider transaction that took place on Jul 09 ’24, was worth 152,085. In this transaction CHIEF MEDICAL OFFICER of this company bought 12,069 shares at a rate of $12.60, taking the stock ownership to the 36,920 shares. Before that another transaction happened on Jul 10 ’24, when Company’s CHIEF MEDICAL OFFICER bought 2,931 for $13.22, making the entire transaction worth $38,748. This insider now owns 39,851 shares in total.
Alto Neuroscience Inc. (ANRO) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 6/30/2024, the organization reported -7.77 earnings per share (EPS), lower than consensus estimate (set at -1.67) by -6.1. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.65 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 73.16% per share during the next fiscal year.
Alto Neuroscience Inc. (NYSE: ANRO) Trading Performance Indicators
Take a look at Alto Neuroscience Inc.’s (ANRO) current performance indicators. Last quarter, stock had a quick ratio of 19.85.
Technical Analysis of Alto Neuroscience Inc. (ANRO)
The latest stats from [Alto Neuroscience Inc., ANRO] show that its last 5-days average volume of 0.34 million was superior to 0.22 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 29.42%. Additionally, its Average True Range was 0.85.
During the past 100 days, Alto Neuroscience Inc.’s (ANRO) raw stochastic average was set at 32.47%, which indicates a significant decrease from 32.50% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 75.82% in the past 14 days, which was lower than the 83.87% volatility it showed in the past 100 days.
Now, the first resistance to watch is $11.29. This is followed by the second major resistance level at $11.53. The third major resistance level sits at $12.02. If the price goes on to break the first support level at $10.56, it is likely to go to the next support level at $10.07. Assuming the price breaks the second support level, the third support level stands at $9.83.
Alto Neuroscience Inc. (NYSE: ANRO) Key Stats
The company with the Market Capitalisation of 297.64 million has total of 26,884K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -36,310 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -16,030 K.
